Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lupin Tiotropium Bromide vs Spiriva in COPD
NCT03137992Phase 3Completed
- Sponsor
- Lupin Limited
- Start
- Nov 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tiotropium in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Lupin Limited. Primary endpoints: Baseline Adjusted Mean Change in FEV1 AUC0-24h Post Dose and Difference in Baseline Adjusted FEV1 AUC0-24h for Comparison of Test and Reference to Placebo. Started Nov 2017; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03137992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03137992.